TER
Q3 2026 EPS Estimate
$2.04
Jul 29, 2026 · Reports after close
Revenue Estimate
$1.22B
FY2026E EPS$7.46
FY2027E EPS$10.05

Analyst Sentiment

Wall St. Consensus
Buy
20 analysts·High coverage
69
Score
15 Buy (75%)5 Hold (25%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1575%
Hold
525%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$220.00
-49.6%
Consensus
$387.00
-11.4%
Bull
$446.00
+2.1%
12-Month Target Range20 analysts
$220.00$387.00$446.00
Current $436.86Consensus
Current Price
$436.86
Above Consensus
$49.86

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+22.09%
EPS+34.72%
FY2028
Rev+24.97%
EPS+35.21%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$4.54B$5.54B$6.92B
Low$4.41B$4.44B$6.83B
High$4.76B$6.43B$7.02B
EBITDA Avg$1.27B$1.55B$1.93B
Low$1.23B$1.24B$1.90B
High$1.33B$1.79B$1.96B
EBIT Avg$1.09B$1.33B$1.66B
Low$1.06B$1.07B$1.64B
High$1.14B$1.55B$1.69B
Net Income Avg$1.11B$1.47B$2.01B
Low$1.05B$1.21B$1.59B
High$1.33B$1.93B$2.84B
EPS Avg$7.46$10.05$13.58
Low$6.65$7.66$10.10
High$8.45$12.27$17.98
Analysts (Rev / EPS)12 / 1114 / 1110 / 5
Quarterly
MetricQ2 2026Q3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$1.22B$1.05B$996M$1.25B$1.40B$1.42B$1.41B$1.68B
Low$1.20B$983M$939M$1.18B$1.32B$1.34B$1.33B$1.59B
High$1.25B$1.11B$1.06B$1.33B$1.48B$1.51B$1.50B$1.79B
EBITDA Avg$339M$293M$278M$349M$390M$397M$393M$470M
Low$334M$274M$262M$329M$368M$374M$371M$443M
High$348M$310M$295M$370M$414M$421M$417M$498M
EBIT Avg$292M$253M$240M$301M$337M$342M$339M$405M
Low$288M$236M$226M$283M$317M$322M$320M$382M
High$300M$267M$254M$319M$357M$363M$360M$430M
Net Income Avg$325M$237M$216M$345M$407M$426M$415M$553M
Low$289M$184M$200M$319M$376M$394M$384M$512M
High$334M$286M$233M$372M$439M$460M$448M$597M
EPS Avg$2.06$1.50$1.37$2.19$2.58$2.70$2.64$3.51
Low$1.83$1.17$1.27$2.03$2.39$2.50$2.44$3.25
High$2.12$1.81$1.48$2.36$2.78$2.92$2.84$3.79
Analysts (Rev / EPS)9 / 119 / 106 / 87 / 84 / 84 / 87 / 87 / 9

Earnings Surprises

Recent Analyst Actions

Jun 23, 2026Robert W. Baird
Teradyne price target raised to $446 from $350 at Baird
Target:$446.00
-2.4%from $457.00
Apr 30, 2026Morgan Stanley
Teradyne price target raised to $387 from $376 at Morgan Stanley
Target:$387.00
+10.2%from $351.03
Apr 30, 2026Evercore ISI
Teradyne price target lowered to $370 from $430 at Evercore ISI
Target:$370.00
+7.1%from $345.56
Apr 30, 2026Goldman Sachs
Teradyne price target raised to $350 from $300 at Goldman Sachs
Target:$350.00
+0.4%from $348.74
Apr 30, 2026Robert W. Baird
Teradyne price target raised to $350 from $332 at Baird
Target:$350.00
+14.3%from $306.33
Apr 28, 2026Stifel Nicolaus
Teradyne price target raised to $390 from $325 at Stifel
Target:$390.00
-3.0%from $402.00
Apr 27, 2026Evercore ISI
Teradyne price target raised to $430 from $320 at Evercore ISI
Target:$430.00
+7.0%from $401.98
Apr 21, 2026UBS
Teradyne price target raised to $440 from $325 at UBS
Target:$440.00
+17.3%from $375.21
Apr 9, 2026Susquehanna
Teradyne price target raised to $415 from $335 at Susquehanna
Target:$415.00
+13.9%from $364.21
Apr 9, 2026Cantor Fitzgerald
Teradyne price target raised to $400 from $330 at Cantor Fitzgerald
Target:$400.00
+9.8%from $364.21
Feb 11, 2026Morgan Stanley
Teradyne (TER) PT Raised to $306 at Morgan Stanley
Target:$306.00
-3.8%from $318.09
Feb 4, 2026Northland Securities
Teradyne downgraded to Market Perform at Northland on valuation
Target:$270.00
-4.0%from $281.29
Feb 4, 2026Stifel Nicolaus
Teradyne price target raised to $325 from $280 at Stifel
Target:$325.00
+15.9%from $280.38
Feb 4, 2026Susquehanna
Teradyne price target raised to $335 from $275 at Susquehanna
Target:$335.00
+19.8%from $279.60
Feb 4, 2026Robert W. Baird
Teradyne price target raised to $305 from $195 at Baird
Target:$305.00
+7.8%from $282.98
Feb 3, 2026Goldman Sachs
Teradyne price target raised to $300 from $230 at Goldman Sachs
Target:$300.00
+6.0%from $282.98
Feb 3, 2026Morgan Stanley
Teradyne price target raised to $288 from $229 at Morgan Stanley
Target:$288.00
+1.8%from $282.98
Feb 3, 2026Cantor Fitzgerald
Cantor Fitzgerald Reiterates Overweight Rating on Teradyne (TER) Post 'Absolute Blowout' Q4 Print
Target:$270.00
-3.1%from $278.68
Feb 2, 2026Evercore ISI
Teradyne price target raised to $280 from $200 at Evercore ISI
Target:$280.00
+13.5%from $246.76
Feb 2, 2026RBC Capital
Teradyne (TER) PT Raised to $270 at Cantor Fitzgerald: Upbeat Messaging Expected
Target:$270.00
+6.8%from $252.90
Jan 30, 2026Stifel Nicolaus
Teradyne price target raised to $280 from $270 at Stifel
Target:$280.00
+11.2%from $251.87
Jan 26, 2026UBS
Teradyne price target raised to $275 from $200 at UBS
Target:$275.00
+17.3%from $234.49
Jan 14, 2026Stifel Nicolaus
Teradyne price target raised to $270 from $225 at Stifel
Target:$270.00
+19.4%from $226.08
Jan 12, 2026Susquehanna
Teradyne price target raised to $275 from $215 at Susquehanna
Target:$275.00
+26.6%from $217.26
Jan 9, 2026Vertical Research
Teradyne downgraded to Hold from Buy at Vertical Research
Target:$220.00
+0.9%from $218.05
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.